Exact Sciences
EXAS
#1992
Rank
NZ$13.01 B
Marketcap
$70.07
Share price
-1.61%
Change (1 day)
-34.46%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -NZ$1.79 Billion

According to Exact Sciences's latest financial reports the company's current earnings are NZ$2.75 Billion. a decrease over its 2023 earnings that were of -NZ$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$1.72 Billion435.08%
2023 -NZ$0.32 Billion-69.28%
2022 -NZ$1.05 Billion-25.55%
2021 -NZ$1.4 Billion1.68%
2020 -NZ$1.38 Billion271.17%
2019 -NZ$0.38 Billion58.99%
2018 -NZ$0.24 Billion20.89%
2017 -NZ$0.2 Billion-30.95%
2016 -NZ$0.28 Billion5.09%
2015 -NZ$0.27 Billion57.24%
2014 -NZ$0.17 Billion116.53%
2013 -NZ$78.02 Million
2011 -NZ$48.58 Million143.73%
2010 -NZ$19.93 Million27.85%
2009 -NZ$15.59 Million0.27%
2008 -NZ$15.55 Million-20.95%
2007 -NZ$19.67 Million-13.53%
2006 -NZ$22.75 Million-10.07%
2005 -NZ$25.3 Million-21.81%
2004 -NZ$32.35 Million-33.44%
2003 -NZ$48.6 Million-6.51%
2002 -NZ$51.98 Million17.95%
2001 -NZ$44.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.21 Billion-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.11 B-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$43.38 M-102.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$58.93 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.38 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France